1.
Wilkinson A, Parker M, Martineau F, Leach M. Engaging ‘communities’: anthropological
insights from the West African Ebola epidemic. Philosophical Transactions of the Royal
Society B: Biological Sciences. 2017;372(1721):20160305.
2.
Ahmed SM, Palermo A-GS. Community Engagement in Research: Frameworks for Education
and Peer Review. Am J Public Health. 2010;100(8):1380-7.
3.
Dickert N, Sugarman J. Ethical Goals of Community Consultation in Research. Am J Public
Health. 2005;95(7):1123-7.
4.
Aggett S. Turning the gaze: challenges of involving biomedical researchers in community
engagement with research in Patan, Nepal. Critical Public Health. 2018;28(3):306-17.
5.
MacQueen KM, Bhan A, Frohlich J, Holzer J, Sugarman J, the Ethics Working Group of
the HIVPTN. Evaluating community engagement in global health research: the need for
metrics. BMC Medical Ethics. 2015;16:44.
6.
Tindana PO, Singh JA, Tracy CS, Upshur REG, Daar AS, Singer PA, et al. Grand Challenges
in Global Health: Community Engagement in Research in Developing Countries. PLOS Medicine.
2007;4(9):e273.
7.
Holzer JK, Ellis L, Merritt MW. Why We Need Community Engagement in Medical Research.
Journal of investigative medicine : the official publication of the American Federation
for Clinical Research. 2014;62(6):851-5.
8.
Yarborough M, Edwards K, Espinoza P, Geller G, Sarwal A, Sharp R, et al. Relationships
Hold the Key to Trustworthy and Productive Translational Science: Recommendations
for Expanding Community Engagement in Biomedical Research. Clinical and Translational
Science. 2013;6(4):310-3.
9.
Marsh V, Kamuya D, Rowa Y, Gikonyo C, Molyneux S. Beginning community engagement at
a busy biomedical research programme: Experiences from the KEMRI CGMRC-Wellcome Trust
Research Programme, Kilifi, Kenya. Social Science & Medicine (1982). 2008;67(5):721-33.
10.
Lavery JV, Tinadana PO, Scott TW, Harrington LC, Ramsey JM, Ytuarte-Nuñez C, et al.
Towards a framework for community engagement in global health research. Trends in
Parasitology. 2010;26(6):279-83.
11.
Gikonyo C, Bejon P, Marsh V, Molyneux S. Taking social relationships seriously: Lessons
learned from the informed consent practices of a vaccine trial on the Kenyan Coast.
Social Science & Medicine (1982). 2008;67(5):708-20.
12.
UNAIDS/AVAC. Good participatory practice: Guidelines for biomedical HIV prevention
trials 2011. 2011.
13.
Kutywayo A, Yah CS, Naidoo NP, Malotana M, Dyani S, Mullick S. Implementing the Good
Participatory Practice Guidelines in the Girls Achieve Power Trial in South Africa.
SAGE Open. 2018;8(4):2158244018809149.
14.
Hannah S, Warren M, Bass E. Global implementation of Good Participatory Practice Guidelines
for biomedical HIV prevention research: charting progress and setting milestones.
Retrovirology. 2012;9(2):P240.
15.
Fairhead J, Leach M, Small M. PUBLIC ENGAGEMENT WITH SCIENCE? LOCAL UNDERSTANDINGS
OF A VACCINE TRIAL IN THE GAMBIA. Journal of Biosocial Science. 2006;38(1):103-16.
16.
Marsh VM, Kamuya DM, Mlamba AM, Williams TN, Molyneux SS. Experiences with community
engagement and informed consent in a genetic cohort study of severe childhood diseases
in Kenya. BMC Medical Ethics. 2010;11(1):13.
17.
Attree P, French B, Milton B, Povall S, Whitehead M, Popay J. The experience of community
engagement for individuals: a rapid review of evidence. Health & social care in the
community. 2011;19(3):250-60.
18.
Fregonese F. Community involvement in biomedical research conducted in the global
health context; what can be done to make it really matter? BMC medical ethics. 2018;19(Suppl
1):44-.
19.
McCoy DC, Hall JA, Ridge M. A systematic review of the literature for evidence on
health facility committees in low- and middle-income countries. Health policy and
planning. 2012;27(6):449-66.
21.
Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ, Kanneh L, et al. Genomic surveillance
elucidates Ebola virus origin and transmission during the 2014 outbreak. Science.
2014;345(6202):1369-72.
23.
Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, et al. Strategies
for containing Ebola in West Africa. Science. 2014;346(6212):991.
24.
Galvani AP, Ndeffo-Mbah ML, Wenzel N, Childs JE. Ebola vaccination: If not now, when?
Annals of Internal Medicine. 2014;161(10):749-50.
25.
Frieden TR, Damon I, Bell BP, Kenyon T, Nichol S. Ebola 2014 — New Challenges, New
Global Response and Responsibility. New England Journal of Medicine. 2014;371(13):1177-80.
26.
Kamradt-Scott A. WHO’s to blame? The World Health Organization and the 2014 Ebola
outbreak in West Africa. Third World Quarterly. 2016;37(3):401-18.
27.
Coltart CEM, Lindsey B, Ghinai I, Johnson AM, Heymann DL. The Ebola outbreak, 2013–2016:
old lessons for new epidemics. Philosophical Transactions of the Royal Society B:
Biological Sciences. 2017;372(1721).
28.
Thiam S, Delamou A, Camara S, Carter J, Lama EK, Ndiaye B, et al. Challenges in controlling
the Ebola outbreak in two prefectures in Guinea: why did communities continue to resist?
The Pan African Medical Journal. 2015;22(Suppl 1):22.
29.
Tiffany A, Dalziel BD, Kagume Njenge H, Johnson G, Nugba Ballah R, James D, et al.
Estimating the number of secondary Ebola cases resulting from an unsafe burial and
risk factors for transmission during the West Africa Ebola epidemic. PLoS neglected
tropical diseases. 2017;11(6):e0005491-e.
30.
Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, et al. Transmission dynamics of
Ebola virus disease and intervention effectiveness in Sierra Leone. Proc Natl Acad
Sci U S A. 2016;113(16):4488-93.
31.
Enria L, Lees S, Smout E, Mooney T, Tengbeh AF, Leigh B, et al. Power, fairness and
trust: understanding and engaging with vaccine trial participants and communities
in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone. BMC Public Health.
2016;16:1140.
32.
Abramowitz SA, McLean KE, McKune SL, Bardosh KL, Fallah M, Monger J, et al. Community-Centered
Responses to Ebola in Urban Liberia: The View from Below. PLOS Neglected Tropical
Diseases. 2015;9(4):e0003706.
33.
Laverack G, Manoncourt E. Key experiences of community engagement and social mobilization
in the Ebola response. Global Health Promotion. 2015;23(1):79-82.
34.
Mooney T, Smout E, Leigh B, Greenwood B, Enria L, Ishola D, et al. EBOVAC-Salone:
Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country.
Clin Trials. 2018:1740774518780678.
35.
Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the
analysis of qualitative data in multi-disciplinary health research. BMC Medical Research
Methodology. 2013;13(1):117.
36.
Shukarev G, Callendret B, Luhn K, Douoguih M. A two-dose heterologous prime-boost
vaccine regimen eliciting sustained immune responses to Ebola Zaire could support
a preventive strategy for future outbreaks. Hum Vaccin Immunother. 2017;13(2):266-70.
37.
Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence
gap. The Lancet. 2011;378(9790):526-35.
38.
Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine
hesitancy around vaccines and vaccination from a global perspective: A systematic
review of published literature, 2007–2012. Vaccine. 2014;32(19):2150-9.
39.
Larson HJ. Negotiating vaccine acceptance in an era of reluctance. Hum Vaccin Immunother.
2013;9(8):1779-81.
40.
Lancet T. Ebola in west Africa: gaining community trust and confidence. The Lancet.
2014;383(9933):1946.
41.
Karamouzian M, Hategekimana C. Ebola treatment and prevention are not the only battles:
understanding Ebola-related fear and stigma. Int J Health Policy Manag. 2014;4(1):55-6.
42.
Gsell P-S, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Nadlaou SD, et al. Ring
vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola
virus disease in Guinea, 2016: an operational and vaccine safety report. The Lancet
Infectious Diseases. 2017;17(12):1276-84.
43.
Larson HJ, Ghinai I. Lessons from polio eradication. Nature. 2011;473:446.
44.
Shagi C, Vallely A, Kasindi S, Chiduo B, Desmond N, Soteli S, et al. A model for community
representation and participation in HIV prevention trials among women who engage in
transactional sex in Africa. AIDS Care. 2008;20(9):1039-49.
45.
Tengbeh AF, Enria L, Smout E, Mooney T, Callaghan M, Ishola D, et al. “We are the
heroes because we are ready to die for this country”: Participants' decision-making
and grounded ethics in an Ebola vaccine clinical trial. Social Science & Medicine.
2018;203:35-42.
48.
Okello G, Jones C, Bonareri M, Ndegwa SN, Mcharo C, Kengo J, et al. Challenges for
consent and community engagement in the conduct of cluster randomized trial among
school children in low income settings: experiences from Kenya. Trials. 2013;14(1):142.
49.
Newman PA, Rubincam C, Slack C, Essack Z, Chakrapani V, Chuang D-M, et al. Towards
a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials:
An Embedded Four-Country Case Study. PloS one. 2015;10(8):e0135937-e.
50.
Molyneux S, Bull S. Consent and Community Engagement in Diverse Research Contexts:
Reviewing and Developing Research and Practice: Participants in the Community Engagement
and Consent Workshop, Kilifi, Kenya, March 2011. Journal of Empirical Research on
Human Research Ethics. 2013;8(4):1-18.